Alprolix - Articles and news items

Alprolix approved in Switzerland for the treatment of haemophilia B

Industry news / 31 October 2016 / Niamh Louise Marriott, Digital Content Producer

The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+